119 related articles for article (PubMed ID: 34291843)
1. A novel method for the quantification of anlotinib in human plasma using two-dimensional liquid chromatography.
Li Z; Chen H; Shi J; Wang F; Liu Y
Biomed Chromatogr; 2021 Dec; 35(12):e5218. PubMed ID: 34291843
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous Quantitation of Anlotinib and Osimertinib by Isotope-Labeled UHPLC-MS/MS in Human Plasma: Application in NSCLC Patients.
Liu Y; Lin Z; Luo W; Pei X; She Z; Sha Z; Guan Y; Ming D; Liang J
J Chromatogr Sci; 2024 Apr; 62(4):339-346. PubMed ID: 37070405
[TBL] [Abstract][Full Text] [Related]
3. A selective and robust UPLC-MS/MS method for the simultaneous quantitative determination of anlotinib, ceritinib and ibrutinib in rat plasma and its application to a pharmacokinetic study.
Du P; Guan Y; An Z; Li P; Liu L
Analyst; 2019 Sep; 144(18):5462-5471. PubMed ID: 31380858
[TBL] [Abstract][Full Text] [Related]
4. A rapid and sensitive ultra-performance liquid chromatography tandem mass spectrometry method for determination of anlotinib in plasma and dried blood spots: Method development, validation, and clinical application.
Zhang J; Wang W; Du J; Li C; Wang S; Han Y; Wang H; Zong H; Cheng Z; Tian X
Rapid Commun Mass Spectrom; 2022 Nov; 36(21):e9372. PubMed ID: 35918299
[TBL] [Abstract][Full Text] [Related]
5. Determination of intracellular anlotinib, osimertinib, afatinib and gefitinib accumulations in human brain microvascular endothelial cells by liquid chromatography/tandem mass spectrometry.
Ma Z; Lu S; Zhou H; Zhang S; Wang Y; Lin N
Rapid Commun Mass Spectrom; 2021 Jan; 35(1):e8955. PubMed ID: 32990383
[TBL] [Abstract][Full Text] [Related]
6. A novel and nonderivatization method for the determination of valproic acid in human serum by two-dimensional liquid chromatography.
Liu W; Shang X; Yao S; Wang F
Biomed Chromatogr; 2020 Jan; 34(1):e4695. PubMed ID: 31469425
[TBL] [Abstract][Full Text] [Related]
7. Establishment and validation of a LC-MS/MS method for the determination of anlotinib in human plasma: Application to therapeutic drug monitoring.
Yu M; Liang Z; Xiong L; Liu F; Cheng L; Jia C; Qi X; Sun F
Biomed Chromatogr; 2022 Dec; 36(12):e5501. PubMed ID: 36082703
[TBL] [Abstract][Full Text] [Related]
8. A rapid, simple and sensitive LC-MS/MS method for lenvatinib quantification in human plasma for therapeutic drug monitoring.
Zanchetta M; Iacuzzi V; Posocco B; Bortolin G; Poetto AS; Orleni M; Canil G; Guardascione M; Foltran L; Fanotto V; Puglisi F; Gagno S; Toffoli G
PLoS One; 2021; 16(10):e0259137. PubMed ID: 34699578
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous determination of sunitinib and its two metabolites in plasma of Chinese patients with metastatic renal cell carcinoma by liquid chromatography-tandem mass spectrometry.
Qiu F; Bian W; Li J; Ge Z
Biomed Chromatogr; 2013 May; 27(5):615-21. PubMed ID: 23108983
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry.
Haouala A; Zanolari B; Rochat B; Montemurro M; Zaman K; Duchosal MA; Ris HB; Leyvraz S; Widmer N; Decosterd LA
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(22):1982-96. PubMed ID: 19505856
[TBL] [Abstract][Full Text] [Related]
11. A LC/MS/MS micro-method for human plasma quantification of vemurafenib. Application to treated melanoma patients.
Alvarez JC; Funck-Brentano E; Abe E; Etting I; Saiag P; Knapp A
J Pharm Biomed Anal; 2014 Aug; 97():29-32. PubMed ID: 24814993
[TBL] [Abstract][Full Text] [Related]
12. Novel high-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification of BCR-ABL and Bruton's tyrosine kinase inhibitors and their three active metabolites in human plasma.
Mukai Y; Yoshida T; Kondo T; Inotsume N; Toda T
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Jan; 1137():121928. PubMed ID: 31877431
[TBL] [Abstract][Full Text] [Related]
13. Quantitation of unbound sunitinib and its metabolite N-desethyl sunitinib (SU12662) in human plasma by equilibrium dialysis and liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study.
Rais R; Zhao M; He P; Xu L; Deeken JF; Rudek MA
Biomed Chromatogr; 2012 Nov; 26(11):1315-24. PubMed ID: 22259028
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous determination of subutinib and its active metabolite in human plasma by LC-MS/MS: Application to pharmacokinetic study.
Ding LK; Yang L; Chen SN; Li JK; Wen AD
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1001():22-6. PubMed ID: 26253807
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a high-performance liquid chromatography-tandem mass spectrometry assay quantifying vemurafenib in human plasma.
Nijenhuis CM; Rosing H; Schellens JH; Beijnen JH
J Pharm Biomed Anal; 2014 Jan; 88():630-5. PubMed ID: 24216282
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous and rapid determination of 12 tyrosine kinase inhibitors by LC-MS/MS in human plasma: Application to therapeutic drug monitoring in patients with non-small cell lung cancer.
Zhou L; Wang S; Chen M; Huang S; Zhang M; Bao W; Bao A; Zhang P; Guo H; Liu Z; Xie G; Gao J; Wu Z; Lou Y; Fan G
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jun; 1175():122752. PubMed ID: 33991955
[TBL] [Abstract][Full Text] [Related]
17. A novel and sensitive method for determination of amisulpride in human plasma by two-dimensional liquid chromatography.
Qu K; Wang F; Du Z; Wang S; Zhang Z; Shen Y
Biomed Chromatogr; 2021 Oct; 35(10):e5149. PubMed ID: 33928659
[TBL] [Abstract][Full Text] [Related]
18. A phase I study investigation of metabolism, and disposition of [
Liu Y; Liu L; Liu L; Wang T; Guo L; Wang Y; Gao Z; Shu Y
Cancer Chemother Pharmacol; 2020 May; 85(5):907-915. PubMed ID: 32266457
[TBL] [Abstract][Full Text] [Related]
19. A simple and rapid liquid chromatography-mass spectrometry method to assay cabozantinib in plasma: Application to therapeutic drug monitoring in patients with renal cell carcinoma.
Ferrer F; Solas C; Giocanti M; Lacarelle B; Deville JL; Gravis G; Ciccolini J
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Feb; 1138():121968. PubMed ID: 31931326
[TBL] [Abstract][Full Text] [Related]
20. Determination of henatinib in human plasma and urine by liquid chromatography-tandem mass spectrometry and its pharmacokinetic application.
Qian J; Wang Y; Cao J; Li J
J Pharm Biomed Anal; 2013 Jun; 80():173-9. PubMed ID: 23587531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
